Entry |
|
Name |
Cyclopentolate (INN); Bell Pentolate (TN) |
Formula |
C17H25NO3
|
Exact mass |
291.1834
|
Mol weight |
291.38
|
Structure |
|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
|
Remark |
Product (DG01141): | D01002<JP/US> |
|
Efficacy |
Mydriatic, Muscarinic acetylcholine receptor antagonist |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
map07220 | Cholinergic and anticholinergic drugs |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01F MYDRIATICS AND CYCLOPLEGICS
S01FA Anticholinergics
S01FA04 Cyclopentolate
D07759 Cyclopentolate (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01141 Cyclopentolate
D07759 Cyclopentolate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D07759 Cyclopentolate (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01141 Cyclopentolate
|
Other DBs |
|
KCF data |
ATOM 21
1 C8x C 29.6100 -19.0400
2 C8x C 29.6100 -20.4400
3 C8x C 28.3500 -21.1400
4 C8x C 27.1600 -20.4400
5 C8y C 27.1600 -19.0400
6 C8x C 28.3500 -18.3400
7 C1c C 25.9000 -18.3400
8 C7a C 24.7100 -19.0400
9 C1z C 25.9000 -16.9400
10 C1x C 24.7800 -16.1000
11 C1x C 25.2000 -14.7700
12 C1x C 26.6000 -14.7700
13 C1x C 27.0200 -16.1000
14 O7a O 23.5200 -18.3400
15 C1b C 22.3300 -19.0400
16 O6a O 24.7100 -20.4400
17 C1b C 21.1400 -18.3400
18 N1c N 19.9500 -19.0400
19 C1a C 18.6900 -18.3400
20 O1a O 27.3000 -16.9400
21 C1a C 19.8800 -20.4400
BOND 22
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 7 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 9 13 1
15 8 14 1
16 14 15 1
17 8 16 2
18 15 17 1
19 17 18 1
20 18 19 1
21 9 20 1
22 18 21 1
|